Professional Financial Advisors LLC Acquires 132 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Professional Financial Advisors LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.9% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,054 shares of the healthcare conglomerate’s stock after buying an additional 132 shares during the period. Professional Financial Advisors LLC’s holdings in UnitedHealth Group were worth $1,082,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently modified their holdings of UNH. Robbins Farley purchased a new stake in UnitedHealth Group in the 3rd quarter valued at $25,000. Richelieu Gestion SA purchased a new stake in UnitedHealth Group in the 4th quarter valued at $26,000. CGC Financial Services LLC increased its position in shares of UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 50 shares during the last quarter. NewSquare Capital LLC increased its position in shares of UnitedHealth Group by 340.0% during the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 51 shares during the last quarter. Finally, Strategic Investment Solutions Inc. IL purchased a new stake in shares of UnitedHealth Group during the 1st quarter valued at $35,000. 87.86% of the stock is currently owned by institutional investors.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In other news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on UNH shares. Barclays initiated coverage on UnitedHealth Group in a research report on Wednesday, March 6th. They set an “overweight” rating and a $551.00 target price for the company. Stephens restated an “overweight” rating and issued a $605.00 target price on shares of UnitedHealth Group in a research note on Thursday, February 8th. Oppenheimer restated an “outperform” rating and issued a $610.00 target price on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a research note on Friday, January 19th. Finally, Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. One analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $579.33.

UnitedHealth Group Stock Down 0.1 %

Shares of NYSE UNH traded down $0.65 during mid-day trading on Thursday, hitting $492.45. 1,173,471 shares of the stock traded hands, compared to its average volume of 4,050,326. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79. UnitedHealth Group Incorporated has a 52 week low of $445.68 and a 52 week high of $554.70. The company has a market cap of $454.00 billion, a price-to-earnings ratio of 20.64, a PEG ratio of 1.34 and a beta of 0.54. The stock has a fifty day moving average price of $503.73 and a 200-day moving average price of $518.79.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, beating the consensus estimate of $5.98 by $0.18. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The company had revenue of $94.43 billion for the quarter, compared to analyst estimates of $92.13 billion. During the same period in the previous year, the company posted $5.34 earnings per share. The firm’s revenue was up 14.1% on a year-over-year basis. Research analysts anticipate that UnitedHealth Group Incorporated will post 27.82 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.53%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s payout ratio is currently 31.54%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.